Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis-Reference-Cited by-同舟云学术

Possible Involvement of Multidrug-Resistant Hepatitis B Virus sW172* Truncation Variant in the ER Stress Signaling Pathway during Hepatocarcinogenesis

Published:2016 Issue:4 Volume:69 Page:306-313
ISSN:1344-6304
Container-title:Japanese Journal of Infectious Diseases
language:en
Short-container-title:Jpn J Infect Dis

Author:

Zheng Jiajia¹²,Jiang Suzhen³,Lu Fengmin²

Affiliation:

1. Department of Laboratory Medicine, Peking University Third Hospital

2. Centers for the Infectious Disease & the Department of Microbiology, Peking University Health Science Center

3. Department of Infectious Disease, Peking University International Hospital

Publisher

Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://www.jstage.jst.go.jp/article/yoken/69/4/69_JJID.2015.359/_pdf

Reference29 articles.

1. 1. Lee WM. Hepatitis B virus infection. N Engl J Med. 1997;337:1733-45.

2. 2. Durantel D, Brunelle MN, Gros E, et al. Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing. J Clin Virol. 2005; 34 Suppl 1:S34-S43.

3. 3. Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009;137:1593-608.

4. 4. Yeh CT. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy. Antivir Ther. 2010;15:471-5.

5. 5. Lee YS, Suh DJ, Lim YS, et al. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology. 2006;43:1385-91.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation;Antiviral Research;2018-06